Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MOREPEN LABS Gains 8%; BSE HEALTHCARE Index Up 0.7%
Wed, 21 Aug 9:59

MOREPEN LABS Gains 8%; BSE HEALTHCARE Index Up 0.7%Image source: Sefa Ozel/www.istockphoto.com

MOREPEN LABS share price has zoomed 8% and is presently trading at Rs 73.3.

Meanwhile, the BSE HEALTHCARE index is at 41,917.5 (up 0.7%).

Among the top gainers in the BSE HEALTHCARE index today are Divis Laboratories (up 3.3%) and ALEMBIC PHARMA (up 2.6%).

Aurobindo Pharma (down 1.2%) and POLY MEDICURE (down 0.7%) are among the top losers today.

Over the last one year, MOREPEN LABS has moved up from Rs 37.1 to Rs 73.3, registering a gain of Rs 36.2 (up 97.7%).

On the other hand, the BSE HEALTHCARE index has moved up from 28,021.8 to 41,917.5, registering a gain of 49.6% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were GRANULES INDIA (up 128.3%), Glenmark Pharma (up 114.7%) and GSK Pharma (up 111.6%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 80,701.0 (down 0.1%).

The top losers among the BSE Sensex today are Ultratech Cement (down 1.6%) and Kotak Bank (down 0.9%). The most traded stocks in the BSE Sensex are Tata Steel and Tata Motors.

In the meantime, NSE Nifty is at 24,680.1 (down 0.1%). Ultratech Cement and Kotak Bank are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 65,216.1 to 80,701.0, registering a gain of 15,484.9 points (up 23.7%).

MOREPEN LABS Financial Update...

MOREPEN LABS net profit grew 147.2% YoY to Rs 362 million for the quarter ended June 2024, compared to a profit of Rs 146 million a year ago. Net sales rose 13.5% to Rs 4,552 million during the period as against Rs 4,010 million in April-June 2023.

For the year ended March 2023, MOREPEN LABS reported 62.0% decrease in net profit to Rs 387 million compared to net profit of Rs 1,017 million during FY22. Revenue of the company fell 8.4% to Rs 14,175 million during FY23.

The current Price to earnings ratio of MOREPEN LABS, based on rolling 12 month earnings, stands at 34.0.


Equitymaster requests your view! Post a comment on "MOREPEN LABS Gains 8%; BSE HEALTHCARE Index Up 0.7%". Click here!